Table Of ContentEuropean guidelines for quality assurance in cervical
cancer screening
Second Edition
Editors
M. Arbyn
A. Anttila
J. Jordan
G. Ronco
U. Schenck
N. Segnan
H. G. Wiener
A. Herbert
J. Daniel (technical editor)
L. von Karsa
This document has been prepared with financial support from the European Communities through
the Europe Against Cancer Programme (European Cervical Cancer Screening Network) and the EU
Public Health Programme (European Cancer Network).
The views expressed in this document are those of the authors and do not necessarily reflect the
official position of the European Commission.
Neither the Commission nor any person acting on its behalf can be held responsible for any use
that may be made of the information in this document.
EuropeDirectisaservicetohelpyoufindanswers
toyourquestionsabouttheEuropeanUnion
Freephonenumber(*):
00 800 6 7 8 9 10 11
(*)Certainmobiletelephoneoperatorsdonotallowaccessto00800numbersorthesecalls
maybebilled.
MoreinformationontheEuropeanUnionisavailableontheInternet(http://europa.eu).
Cataloguingdatacanbefoundattheendofthispublication.
Luxembourg:OfficeforOfficialPublicationsoftheEuropeanCommunities,2008
ISBN978-92-79-07698-5
©EuropeanCommunities,2008
PrintedinBelgium
Printedonwhitechlorine-freepaper
II European guidelines for quality assurance in cervical cancer screening – Second edition
E D I T O R S
Marc Arbyn
Unit of Cancer Epidemiology, Department of Epidemiology
Scientific Institute of Public Health
Brussels, Belgium
Ahti Anttila
Mass Screening Registry, Finnish Cancer Registry
Helsinki, Finland
Joe Jordan
Birmingham Women’s Hospital
Birmingham, United Kingdom
Guglielmo Ronco
Unit of Cancer Epidemiology
Centre for Cancer Epidemiology and Prevention (CPO Piemonte)
Turin, Italy
Ulrich Schenck
Institute of Pathology, Technical University
Munich, Germany
Nereo Segnan
Unit of cancer Epidemiology, Department of Oncology
CPO Piemonte (Piedmont Centre for Cancer Prevention) and S. Giovanni Hospital
Turin, Italy
Helene G. Wiener
Clinical Institute of Pathology, Medical University of Vienna
Vienna, Austria
Amanda Herbert
Guy’s & St Thomas’ NHS Foundation Trust
London, United Kingdom
John Daniel
International Agency for Research on Cancer
Lyon, France
Lawrence von Karsa
European Cancer Network (ECN) Coordination Office
Screening Quality Control Group
International Agency for Research on Cancer
Lyon, France
European guidelines for quality assurance in cervical cancer screening – Second edition III
Address for correspondence
European Cancer Network (ECN) Coordination Office
International Agency for Research on Cancer
150 cours Albert Thomas
F-69372 Lyon cedex 08 / France
IV European guidelines for quality assurance in cervical cancer screening – Second edition
C O N T R I B U T O R S
Contributors
Charles Anthony, Center for Public Health and Preventive Medicine
Ormylia, Greece
Ahti Anttila, Mass Screening Registry, Finnish Cancer Registry
Helsinki, Finland
Marc Arbyn, Unit of Cancer Epidemiology, Department of Epidemiology,
Scientific Institute of Public Health
Brussels, Belgium
Joan Austoker, Division of Public Health and Primary Health Care
Oxford, United Kingdom
Jean-Jacques Baldauf, Department of Obstetrics and Gynaecology, Hôpitaux
Universitaires de Strasbourg
Strasbourg, France
Nikolaus Becker, German Cancer Research Centre
Heidelberg, Germany
Christine Bergeron, Laboratoire Pasteur Cerba
Cergy-Pontoise, France
Miklós Bodó, Semmelweis University, I. Pathological Institute
Budapest, Hungary
Peter Boyle
International Agency for Research on Cancer
Lyon, France
Johan Bulten, Institute of Pathology, Radboud University Nijmegen Medical Centre
Nijmegen, The Netherlands
Christine Clavel, Laboratoire Pol Bouin
Reims, France
John Daniel
International Agency for Research on Cancer
Lyon, France
Philip Davies, European Cervical Cancer Association
Lyon, France
European guidelines for quality assurance in cervical cancer screening – Second edition V
C O N T R I B U T O R S
Santiago Dexeus, Instituto Dexeus
Barcelona, Spain
Joakim Dillner, Department of Medical Microbiology, Lund University
Lund, Sweden
Lajos Döbr(cid:280)ssy, Office of Chief Medical Officer
Iklad, Hungary
Muriel Fender, Association EVE
Strasbourg, France
Livia Giordano, CPO Piemonte
Turin, Italy
Matti Hakama, School of Public Health, University of Tampere
Tampere, Finland
Amanda Herbert, Guy’s & St Thomas’ NHS Foundation Trust
London, United Kingdom
Reinhard Horvat, Institute of Pathology
Vienna, Austria
Thomas Iftner, Institute of Medical Virology
Tubingen, Germany
Joe Jordan, Birmingham Women’s Hospital
Birmingham, United Kingdom
Lawrence von Karsa, European Cancer Network
International Agency for Research on Cancer
Lyon, France
Paul Klinkhamer, PAMM
Eindhoven, The Netherlands
Markos Kyprianou
European Commissioner for Health and Consumer Protection
Elsebeth Lynge, Institute of Public Health, University of Copenhagen
Copenhagen, Denmark
Pierre Martin-Hirsch, Department of Obstetrics and Gynaecology, Royal Preston
Hospital
Preston, United Kingdom
VI European guidelines for quality assurance in cervical cancer screening – Second edition
C O N T R I B U T O R S
Euphemia McGoogan, formerly Department of Pathology, University of Edinburgh
Edinburgh, United Kingdom
Anthony B. Miller, Deutsches Krebsforschungzentrum
Heidelberg, Germany
Guillermo Domenech Muniz, Directorate General of Public Health
Junta de Castilla y León, Spain
Pekka Nieminen, Helsinki University Central Hospital
Helsinki, Finland
Sonia Pagliusi, formerly, Initiative for Vaccine Research, Vaccines and Biologicals, Family
and Community Health, WHO
Geneva, Switzerland
Julietta Patnick, National Health System Cervical Cancer Screening Programme
Sheffield, United Kingdom
Walter Prendiville, Coombe Women’s Hospital
Dublin, Ireland
Odette Real, Centro de Oncologia de Coimbra
Coimbra, Portugal
Guglielmo Ronco, Unit of Cancer Epidemiology, CPO Piemonte
Turin, Italy
Amaya Hernandez Rubio, Directorate General of Public Health
Junta de Castilla y León, Spain
Peter Sasieni,Wolfson Institute of Preventive Medicine
London, United Kingdom
Ulrich Schenck, Institute of Pathology, Technical University
Munich, Germany
Nereo Segnan, Unit of cancer Epidemiology, Department of Oncology, CPO Piemonte
and S. Giovanni Hospital
Turin, Italy
Peter Stern, Paterson Institute for Cancer Research
Manchester, United Kingdom
Daniel Da Silva, Centro de Oncologia de Coimbra
Coimbra, Portugal
European guidelines for quality assurance in cervical cancer screening – Second edition VII
C O N T R I B U T O R S
Pär Sparen, Department of Medical Epidemiology and Biostatistics, Karolinska Institute
Stockholm, Sweden
Silvia Tejero Encinas, Regional Health Service – Hospital General Yagüe of Burgos
Junta de Castilla y León, Spain
Anne Szarewski, Imperial Cancer Fund
London, United Kingdom
Premila Webster, Division of Public Health and Primary Health Care
Oxford, United Kingdom
Elisabete Weiderpass, Norwegian Cancer Register
Oslo, Norway
Helene G. Wiener, Clinical Institute of Pathology, Medical University of Vienna
Vienna, Austria
Maja Zakelj, Epidemiology and Cancer Registries, Institute of Oncology
Ljubljana, Slovenia
Conflicts of interest, declared by authors, contributors, editors or reviewers of
chapters of the European Guidelines for Quality Assurance in Cervical Cancer
Screening – Second Edition*
M. Arbyn has received travel grants from producers of HPV vaccines (Smith-Glaxo Kline
and Sanofi Pharmaceuticals, Inc.)
P. Davies has served on the scientific advisory board of Roche Molecular Systems Inc., a
diagnostic test manufacturer, prior to 2007.
J. Dillner is currently a consultant for and a recipient of research grants from a producer of
HPV vaccines (Merck/SPMSD).
T. Iftner is an inventor of patents on a genotyping test ("Primer and probes for detection
of papilloma-viruses", and "detection of human papillomaviruses") whereas the holder of
the patents is either University Hospital Tuebingen or Greiner BioOne.
* Disclosed by experts concerned between August & November 2007. No other potential
conflict of interest relevant to this publication was reported.
VIII European guidelines for quality assurance in cervical cancer screening – Second edition
PPrreeffaacceess
Description:Clinical Institute of Pathology, Medical University of Vienna lesions, high specificity is also required to avoid anxiety, unnecessary treatment and.
